Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BL806

Bladder cancer tissue array, with matched adjacent normal tissue (NAT), including TNM and pathology grade, 80 cases/80 cores, replacing BL801
Unstained: $215.00 Add to Cart
H&E (BL806s*): $215.00 Add to Cart

Microarray Panel:Bladder carcinoma tissue microarray, containing 37 cases of transitional cell carcinoma, 2 squamous cell carcinoma, 1 adenocarcinoma, 40 adjacent normal tissue, single core per case
Cores:80
Cases:80
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Bla Bla Bla Bla Bla Bla Bla Bla Bla Bla  
B Bla Bla Bla Bla Bla Bla Bla Bla Bla Bla  
C Bla Bla Bla Bla Bla Bla Bla Bla Bla Bla  
D Bla Bla Bla Bla Bla Bla Bla Bla Bla Bla  
E Bla Bla Bla Bla Bla Bla Bla Bla Bla Bla  
F Bla Bla Bla Bla Bla Bla Bla Bla Bla Bla  
G Bla Bla Bla Bla Bla Bla Bla Bla Bla Bla  
H Bla Bla Bla Bla Bla Bla Bla Bla Bla Bla Marked point
Legend: Bla - Bladder

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 40 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
A2 2 F 37 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
A3 3 M 62 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
A4 4 M 62 Bladder Transitional cell carcinoma 1 II T2N0M0 Malignant
A5 5 F 75 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
A6 6 M 54 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
A7 7 M 66 Bladder Transitional cell carcinoma 1 II T2N0M0 Malignant
A8 8 M 70 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
A9 9 F 50 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
A10 10 M 42 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
B1 11 M 63 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B2 12 M 49 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B3 13 M 62 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B4 14 M 42 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
B5 15 M 61 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
B6 16 F 72 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B7 17 M 55 Bladder Transitional cell carcinoma 2 II T3aN0M0 Malignant
B8 18 M 78 Bladder Transitional cell carcinoma 3 II T2bN0M0 Malignant
B9 19 M 50 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B10 20 F 66 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
C1 21 M 58 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
C2 22 M 72 Bladder Transitional cell carcinoma 2 II T3aN0M0 Malignant
C3 23 M 72 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
C4 24 M 56 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
C5 25 F 72 Bladder Transitional cell carcinoma 2 II T3N0M0 Malignant
C6 26 M 47 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
C7 27 F 65 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
C8 28 M 66 Bladder Transitional cell carcinoma 2 II T3N0M0 Malignant
C9 29 M 71 Bladder Transitional cell carcinoma 2 II T2bN0M0 Malignant
C10 30 M 45 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
D1 31 F 50 Bladder Transitional cell carcinoma 3 II T2aN0M0 Malignant
D2 32 F 48 Bladder Transitional cell carcinoma 3 II T2bN0M0 Malignant
D3 33 M 65 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
D4 34 M 71 Bladder Transitional cell carcinoma with necrosis 3 III T3biN0M0 Malignant
D5 35 M 58 Bladder Transitional cell carcinoma 2 II T3N0M0 Malignant
D6 36 F 72 Bladder Transitional cell carcinoma 2 II T2bN0M0 Malignant
D7 37 F 45 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
D8 38 M 67 Bladder Squamous cell carcinoma 2 II T3aN0M0 Malignant
D9 39 M 51 Bladder Squamous cell carcinoma 1 II T3aN0M0 Malignant
D10 40 M 50 Bladder Mucinous adenocarcinoma 3 III T3N0M0 Malignant
E1 41 M 40 Bladder Bladder cancer normal adjacent tissue (NAT*) of No.1 – – – NAT
E2 42 F 37 Bladder Cancer adjacent normal bladder tissue of No.2 – – – NAT
E3 43 M 62 Bladder Cancer adjacent normal bladder tissue of No.3 – – – NAT
E4 44 M 62 Bladder Cancer adjacent normal bladder tissue of No.4 – – – NAT
E5 45 F 75 Bladder Cancer adjacent normal bladder tissue (chronic cystitis) of No.5 – – – NAT
E6 46 M 54 Bladder Cancer adjacent normal bladder tissue of No.6 – – – NAT
E7 47 M 66 Bladder Cancer adjacent normal bladder tissue (chronic cystitis) of No.7 – – – NAT
E8 48 M 70 Bladder Cancer adjacent normal bladder tissue of No.8 – – – NAT
E9 49 M 40 Bladder Cancer adjacent normal bladder tissue – – – NAT
E10 50 M 58 Bladder Cancer adjacent normal bladder tissue – – – NAT
F1 51 M 52 Bladder Cancer adjacent normal bladder tissue – – – NAT
F2 52 M 49 Bladder Cancer adjacent normal bladder tissue of No.12 – – – NAT
F3 53 M 56 Bladder Cancer adjacent normal bladder tissue – – – NAT
F4 54 M 42 Bladder Cancer adjacent normal bladder tissue (fibrous tissue, blood vessel and smooth muscle) of No.14 – – – NAT
F5 55 M 61 Bladder Cancer adjacent normal bladder tissue of No.15 – – – NAT
F6 56 F 72 Bladder Cancer adjacent normal bladder tissue of No.16 – – – NAT
F7 57 M 55 Bladder Cancer adjacent normal bladder tissue of No.17 – – – NAT
F8 58 M 78 Bladder Cancer adjacent normal bladder tissue of No.18 – – – NAT
F9 59 M 50 Bladder Cancer adjacent normal bladder tissue of No.19 – – – NAT
F10 60 M 43 Bladder Cancer adjacent normal bladder tissue of No.20 – – – NAT
G1 61 M 58 Bladder Cancer adjacent normal bladder tissue of No.21 – – – NAT
G2 62 M 72 Bladder Cancer adjacent normal bladder tissue of No.22 – – – NAT
G3 63 M 72 Bladder Cancer adjacent normal bladder tissue of No.23 – – – NAT
G4 64 M 56 Bladder Cancer adjacent normal bladder tissue (sparse) of No.24 – – – NAT
G5 65 F 72 Bladder Cancer adjacent normal bladder tissue of No.25 – – – NAT
G6 66 M 65 Bladder Cancer adjacent normal bladder tissue (chronic cystitis) – – – NAT
G7 67 F 71 Bladder Cancer adjacent normal bladder tissue – – – NAT
G8 68 M 60 Bladder Cancer adjacent normal bladder tissue – – – NAT
G9 69 M 70 Bladder Cancer adjacent normal bladder tissue – – – NAT
G10 70 M 79 Bladder Cancer adjacent normal bladder tissue (chronic cystitis) – – – NAT
H1 71 F 50 Bladder Cancer adjacent normal bladder tissue (sparse) of No.31 – – – NAT
H2 72 F 48 Bladder Cancer adjacent normal bladder tissue (chronic cystitis) of No.32 – – – NAT
H3 73 M 49 Bladder Cancer adjacent normal bladder tissue with squamous metaplasia – – – NAT
H4 74 M 71 Bladder Cancer adjacent normal bladder tissue of No.34 – – – NAT
H5 75 M 58 Bladder Cancer adjacent normal bladder tissue of No.35 – – – NAT
H6 76 F 72 Bladder Cancer adjacent normal bladder tissue of No.36 – – – NAT
H7 77 M 68 Bladder Cancer adjacent normal bladder tissue – – – NAT
H8 78 M 67 Bladder Cancer adjacent normal bladder tissue (chronic cystitis) of No.38 – – – NAT
H9 79 M 70 Bladder Cancer adjacent normal bladder tissue (sparse) – – – NAT
H10 80 F 58 Bladder Cancer adjacent normal bladder tissue (fibrous tissue, blood vessel and smooth muscle) – – – NAT
– – F 55 liver Hepatocellular liver cancer (tissue marker) 3 T3N0M0 Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal